332 related articles for article (PubMed ID: 12086949)
1. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.
Nikoulina SE; Ciaraldi TP; Mudaliar S; Carter L; Johnson K; Henry RR
Diabetes; 2002 Jul; 51(7):2190-8. PubMed ID: 12086949
[TBL] [Abstract][Full Text] [Related]
2. The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism.
Summers SA; Kao AW; Kohn AD; Backus GS; Roth RA; Pessin JE; Birnbaum MJ
J Biol Chem; 1999 Jun; 274(25):17934-40. PubMed ID: 10364240
[TBL] [Abstract][Full Text] [Related]
3. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise.
Thong FS; Derave W; Kiens B; Graham TE; Ursø B; Wojtaszewski JF; Hansen BF; Richter EA
Diabetes; 2002 Mar; 51(3):583-90. PubMed ID: 11872654
[TBL] [Abstract][Full Text] [Related]
4. Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.
Henriksen EJ; Teachey MK
Metabolism; 2007 Jul; 56(7):931-8. PubMed ID: 17570255
[TBL] [Abstract][Full Text] [Related]
5. The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells.
Hribal ML; Federici M; Porzio O; Lauro D; Borboni P; Accili D; Lauro R; Sesti G
J Clin Endocrinol Metab; 2000 May; 85(5):2004-13. PubMed ID: 10843189
[TBL] [Abstract][Full Text] [Related]
6. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
[TBL] [Abstract][Full Text] [Related]
7. Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis.
Hurel SJ; Rochford JJ; Borthwick AC; Wells AM; Vandenheede JR; Turnbull DM; Yeaman SJ
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):871-7. PubMed ID: 9003374
[TBL] [Abstract][Full Text] [Related]
8. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
Nikoulina SE; Ciaraldi TP; Mudaliar S; Mohideen P; Carter L; Henry RR
Diabetes; 2000 Feb; 49(2):263-71. PubMed ID: 10868943
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells.
Hajduch E; Alessi DR; Hemmings BA; Hundal HS
Diabetes; 1998 Jul; 47(7):1006-13. PubMed ID: 9648821
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes.
Oreña SJ; Torchia AJ; Garofalo RS
J Biol Chem; 2000 May; 275(21):15765-72. PubMed ID: 10748179
[TBL] [Abstract][Full Text] [Related]
11. Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle.
Liu Z; Wu Y; Nicklas EW; Jahn LA; Price WJ; Barrett EJ
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E523-8. PubMed ID: 14656717
[TBL] [Abstract][Full Text] [Related]
12. Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells.
Halse R; Pearson SL; McCormack JG; Yeaman SJ; Taylor R
Diabetes; 2001 May; 50(5):1102-9. PubMed ID: 11334414
[TBL] [Abstract][Full Text] [Related]
13. Glucose transport rate and glycogen synthase activity both limit skeletal muscle glycogen accumulation.
Fisher JS; Nolte LA; Kawanaka K; Han DH; Jones TE; Holloszy JO
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1214-21. PubMed ID: 12006350
[TBL] [Abstract][Full Text] [Related]
14. Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels.
Henry RR; Ciaraldi TP; Mudaliar S; Abrams L; Nikoulina SE
Diabetes; 1996 Apr; 45(4):400-7. PubMed ID: 8603759
[TBL] [Abstract][Full Text] [Related]
15. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells.
Sweeney G; Keen J; Somwar R; Konrad D; Garg R; Klip A
Endocrinology; 2001 Nov; 142(11):4806-12. PubMed ID: 11606447
[TBL] [Abstract][Full Text] [Related]
16. Effects of cell-permeable ceramides and tumor necrosis factor-alpha on insulin signaling and glucose uptake in 3T3-L1 adipocytes.
Wang CN; O'Brien L; Brindley DN
Diabetes; 1998 Jan; 47(1):24-31. PubMed ID: 9421370
[TBL] [Abstract][Full Text] [Related]
17. Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2.
Chibalin AV; Yu M; Ryder JW; Song XM; Galuska D; Krook A; Wallberg-Henriksson H; Zierath JR
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):38-43. PubMed ID: 10618367
[TBL] [Abstract][Full Text] [Related]
18. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
19. GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle.
Ciaraldi TP; Carter L; Mudaliar S; Henry RR
Mol Cell Endocrinol; 2010 Feb; 315(1-2):153-8. PubMed ID: 19505532
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.
Ruzzin J; Wagman AS; Jensen J
Diabetologia; 2005 Oct; 48(10):2119-30. PubMed ID: 16078016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
